Hallmarks of pluripotency

Alejandro De Los Angeles^{1

2

3}, Francesco Ferrari⁴, Ruibin Xi^{4

5}, Yuko Fujiwara^{1

2

3}, Nissim Benvenisty⁶, Hongkui Deng⁷, Konrad Hochedlinger^{2

3

4

8}, Rudolf Jaenisch⁹, Soohyun Lee⁴, Harry G Leitch¹⁰, M William Lensch^{1

2

3}, Ernesto Lujan¹¹, Duanqing Pei¹², Janet Rossant¹³, Marius Wernig¹¹, Peter J Park⁴, George Q Daley^{1

2

3}

Affiliations

¹ Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
² Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA.
³ Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA.
⁴ Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
⁵ School of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing 100871, China.
⁶ Stem Cell Unit, Department of Genetics, Institute of Life Sciences, The Hebrew University, Jerusalem 91904, Israel.
⁷ College of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
⁸ Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts 02114, USA.
⁹ Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
¹⁰ Medical Research Council Clinical Sciences Centre, Imperial College London, London W12 0NN, United Kingdom.
¹¹ Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.
¹² South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
¹³ The Hospital for Sick Children Research Institute, Toronto, Ontario ON M5G 0A4, Canada.

PMID: 26399828
DOI: 10.1038/nature15515

Review

Hallmarks of pluripotency

Alejandro De Los Angeles et al. Nature. 2015.

. 2015 Sep 24;525(7570):469-78.

doi: 10.1038/nature15515.

Authors

Affiliations

¹ Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
² Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA.
³ Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA.
⁴ Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
⁵ School of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing 100871, China.
⁶ Stem Cell Unit, Department of Genetics, Institute of Life Sciences, The Hebrew University, Jerusalem 91904, Israel.
⁷ College of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
⁸ Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts 02114, USA.
⁹ Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
¹⁰ Medical Research Council Clinical Sciences Centre, Imperial College London, London W12 0NN, United Kingdom.
¹¹ Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.
¹² South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
¹³ The Hospital for Sick Children Research Institute, Toronto, Ontario ON M5G 0A4, Canada.

PMID: 26399828
DOI: 10.1038/nature15515

Erratum in

Corrigendum: Hallmarks of pluripotency.
De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, Park PJ, Daley GQ. De Los Angeles A, et al. Nature. 2016 Mar 17;531(7594):400. doi: 10.1038/nature16470. Epub 2015 Dec 16. Nature. 2016. PMID: 26675727 No abstract available.

Abstract

Stem cells self-renew and generate specialized progeny through differentiation, but vary in the range of cells and tissues they generate, a property called developmental potency. Pluripotent stem cells produce all cells of an organism, while multipotent or unipotent stem cells regenerate only specific lineages or tissues. Defining stem-cell potency relies upon functional assays and diagnostic transcriptional, epigenetic and metabolic states. Here we describe functional and molecular hallmarks of pluripotent stem cells, propose a checklist for their evaluation, and illustrate how forensic genomics can validate their provenance.

PubMed Disclaimer

References

1. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4484-9 - PubMed
1. Nature. 2006 Nov 23;444(7118):481-5 - PubMed
1. Cell. 2012 Jan 20;148(1-2):285-95 - PubMed
1. J Natl Cancer Inst. 1958 Jun;20(6):1257-75 - PubMed
1. Nature. 2010 Jun 24;465(7301):E1; discussion E3 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

Howard Hughes Medical Institute/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hallmarks of pluripotency

Affiliations

Hallmarks of pluripotency

Authors

Affiliations

Erratum in

Abstract

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources